The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Factors associated with effectiveness of trifluridine/tipiracil versus regorafenib in patients with pretreated metastatic colorectal cancer (mCRC).
 
Peter Grell
Travel, Accommodations, Expenses - Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst)
 
Simona Borilova
No Relationships to Disclose
 
Renata Schwanzerova
No Relationships to Disclose
 
Sabina Kukolikova
No Relationships to Disclose
 
Josef Dvorak
No Relationships to Disclose
 
Michal Vocka
No Relationships to Disclose
 
Stanislav John
No Relationships to Disclose
 
Tomas Buchler
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Roche; Roche; Roche; Roche; SERVIER; SERVIER; SERVIER; SERVIER
 
Iveta Selingerova
No Relationships to Disclose
 
Lubos B. Petruzelka
No Relationships to Disclose
 
Rostislav Vyzula
Travel, Accommodations, Expenses - Roche; Roche; Roche; Roche
 
Igor Kiss
Honoraria - Amgen; Amgen; Amgen; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche; SERVIER; SERVIER; SERVIER; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; SERVIER; SERVIER; SERVIER; SERVIER
 
Radka Obermannova
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Roche; Roche; Roche; Roche; SERVIER; SERVIER; SERVIER; SERVIER
Speakers' Bureau - Amgen; Amgen; Amgen; Amgen; Roche; Roche; Roche; Roche
Research Funding - Merck; Merck; Merck; Merck